Back to results
US 2010/0062986 A1Published application
Method to treat blood cell depletion
AssigneeImmuneRegen Biosciences, Inc.
InventorHal Siegel
Life of this patent
Estimating the term…
Abstract
Neuropeptides are used to treat mammals which have depletion of count of one or more blood cell types. Intramuscular administration or administration via inhalation causes the blood cell count to increase.
Claims30
A method for treating depletion of one or more blood cell types, comprising:
- injecting intramuscularly an effective amount of Substance P or an analog thereof to a mammal in which one or more blood cell types is depleted, wherein said analog is selected from the group consisting of [Met-OH11]-substance P, [Met-OMe11]-substance P, [Nle11]-substance P, [Pro9]-substance P, [Sar9]-substance P, [Tyr8]-substance P, [p-Cl-Phe7,8]-substance P, and [Sar9, Met(O2)11]-substance P, wherein the blood cell types are selected from the group consisting of erythrocytes, leukocytes, and platelets, whereby the count of at least one of the blood cell types increases.
23-25. (canceled)
A method for treating depletion of one or more blood cell types, comprising:
- administering an effective amount of Substance P or an analog thereof via inhalation to a mammal in which one or more blood cell types is depleted, wherein said analog is selected from the group consisting of [Met-OH11]-substance P, [Met-OMe11]-substance P, [Nle11]-substance P, [Pro9]-substance P, [Sar9]-substance P, [Tyr8]-substance P, [p-Cl-Phe7,8]-substance P, and [Sar9, Met(O2)11]-substance P, wherein the blood cell types are selected from the group consisting of erythrocytes, leukocytes, and platelets, whereby the count of at least one of the blood cell types increases.
32-60. (canceled)
Dependencies are inferred from the claim text.